Results 11 to 20 of about 3,323,629 (269)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy

open access: yesProstate Cancer, 2012
Androgen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer.
Matthew E. Johnson, Mark K. Buyyounouski
doaj   +2 more sources

Androgen Deprivation Therapy for Prostate Cancer [PDF]

open access: yesJAMA, 2005
Prostate cancer is the most common nonskin cancer and second most common cause of cancer mortality in US men. Androgen deprivation therapy (ADT), specifically surgical or medical castration, is the first line of treatment against advanced prostate cancer and is also used as an adjuvant to local treatment of high-risk disease.To review systematically ...
Nima, Sharifi   +2 more
openaire   +3 more sources

Androgen Deprivation Causes Epithelial–Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy [PDF]

open access: yesCancer Research, 2012
Abstract Androgen deprivation is currently a standard-of-care, first-line therapy for prostate cancer in the United States. Although this regimen effectively regresses androgen-dependent disease, relapse often occurs in an androgen-independent manner and is associated with poor prognosis.
Yuting, Sun   +11 more
openaire   +3 more sources

Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer

open access: yesEinstein (São Paulo), 2019
Objective To evaluate the cost-effectiveness of the addition of chemotherapy or abiraterone to androgen deprivation. Methods We developed an analytical model to determine the cost-effectiveness of the addition of docetaxel or abiraterone versus ...
Pedro Nazareth Aguiar Jr.   +6 more
doaj   +2 more sources

COMBINED RADIATION THERAPY FOR PROSTATE CANCER WITH DOSE ESCALATION BRACHYTHERAPY AND ANDROGEN DEPRIVATION

open access: yesŽurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2018
Background. The efficacy of combined radiation therapy with high dose rate brachytherapy in prostate cancer remains poorly understood. Purpose of the study: To evaluate the effectiveness of combined radiotherapy of prostate cancer and androgen ...
Auchynikau V. A.   +2 more
doaj   +2 more sources

Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer [PDF]

open access: yes, 2023
Androgen deprivation therapy is the cornerstone of prostate cancer therapy. Recent studies have revealed an association between androgen deprivation therapy and cardiovascular adverse effects such as myocardial infarction and stroke.
Eugene Storozynsky   +4 more
core   +4 more sources

Indications and Complications of Androgen Deprivation Therapy [PDF]

open access: yesSeminars in Oncology Nursing, 2020
To review the indications for and side effects of androgen deprivation therapy (ADT) in men affected by prostate cancer.National guidelines, evidence-based summaries, peer-reviewed studies, and websites.Indications for ADT include men with (1) intermediate- to high-risk localised prostate cancer undergoing radiation therapy, (2) biochemical recurrence ...
Fankhauser, Christian Daniel   +5 more
openaire   +3 more sources

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy [PDF]

open access: yes, 2022
BACKGROUND: Androgen deprivation therapy (ADT) worsens glycaemic control and cardiovascular outcomes. The prognostic value of visit-to-visit HbA1c variability (VVHV) has been unexplored in prostate cancer (PCa) patients receiving ADT.
Tse, Gary   +9 more
core   +3 more sources

Cardiovascular Toxicity of Androgen Deprivation Therapy [PDF]

open access: yesCurrent Cardiology Reports, 2021
Androgen deprivation therapy (ADT) is the standard of care for the treatment of advanced prostate cancer (PC). ADT, particularly with GnRH agonists, leads to increased risk of cardiovascular disease, including myocardial infarction, hypertension, and stroke.
Julia Boland   +3 more
openaire   +2 more sources

Androgen Deprivation Therapy and Cardiovascular Risk [PDF]

open access: yesNephro-Urology Monthly, 2012
Androgen deprivation therapy (ADT) is an established therapy for metastatic prostate cancer (PC) and some cases of locally advanced and/or localized PC (1). However, concerns have been raised about the cardiovascular side effects of ADT and their impact on the survival of elderly patients with PC (1).
Mourmouris, P.   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy